共 151 条
[1]
Wong TY(2008)The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis Ophthalmology 115 116-126
[2]
Wong T(2011)Prevalence of age-related macular degeneration in the US population Arch Ophthalmol 129 75-80
[3]
Chakravarthy U(2006)Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363-372
[4]
Mitchell P(2009)Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 57-65
[5]
Zlateva G(2012)Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2537-2548
[6]
Buggage R(2009)A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study Am J Ophthalmol 148 43-58
[7]
Fahrbach K(2014)Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Ophthalmology 121 2181-2192
[8]
Probst C(2007)Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 144 741-746
[9]
Sledge I(2008)Vitreomacular traction and exudative age-related macular degeneration Acta Ophthalmol 86 470-481
[10]
Klein R(2013)Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration Br J Ophthalmol 97 1443-1446